About 30 results found for searched term "Cannabinoid" (0.069 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1907 | Org 27569 | Cannabinoid |
| Org 27569 is a potent and selective allosteric modulator of the cannabinoid CB1 receptor. | ||
| M2012 | AM1241 | Cannabinoid |
| AM1241 is a cannabinoid CB2 receptor selective agonist. | ||
| M2343 | AM-2201 | Cannabinoid |
| AM-2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively. | ||
| M2379 | AM251 | Cannabinoid |
| AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain. | ||
| M2461 | BML-190 | Cannabinoid |
| IMMA | ||
| BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor. | ||
| M3264 | Pravadoline | COX |
| WIN 48098 | ||
| Pravadoline (WIN 48098) is a cyclooxygesase inhibitor and inhibits prostaglandin synthesis with IC50 of 4.9 μM, also a cannabinoid agonist. | ||
| M3266 | WIN 55212-2 mesylate | Cannabinoid |
| (R)-(+)-WIN 55212 | ||
| WIN 55212-2 is a potent nanomolar affinity cannabinoid receptor agonist with Ki of 62.3 and 3.3 nM at the human cloned CB1 and CB2 receptors respectively. | ||
| M3282 | GW842166X | Cannabinoid |
| GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. | ||
| M3404 | URB597 | FAAH |
| KDS-4103 | ||
| URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. | ||
| M45340 | WIN 55212-2 | Cannabinoid |
| (+)-WIN 55,212-2 | ||
| WIN 55212-2 is a non-specific cannabinoid receptor agonist. | ||
| M45341 | Ajulemic acid | Cannabinoid |
| Lenabasum; IP 751 | ||
| Ajulemic acid is a synthetic, orally available Δ9-tetrahydrocannabinol metabolite and cannabinoid receptor agonist with Ki values of 5.7 nM for hCB1 and 56.1 nM for hCB2, and EC50 values of 11.6 nM and 13.4 nM, respectively. | ||
| M45342 | AZD-2207 | Cannabinoid |
| AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound that can be used in studies related to type 2 diabetic disease and obesity. | ||
| M4777 | Pregnenolone | Cannabinoid |
| Arthenolone; 3β-Hydroxy-5-pregnen-20-one | ||
| Pregnenolone (3β -hydroxy-5-pregnen-20-one) is a powerful neurosteroid, and is the major precursor of various steroids, including steroids. Pregnenolone is a specific signaling inhibitor of cannabinoid CB1 receptor. | ||
| M6626 | CP 55,940 | Others |
| CP 55,940 is a potent, non-selective cannabinoid receptor agonist. | ||
| M7325 | Rimonabant Hydrochloride | Cannabinoid |
| SR 141716A; SR 151716A | ||
| Rimonabant hydrochloride is a cannabinoid receptor antagonist, which binds selectively to central cannabinoid receptors (CB1) with high affinity | ||
| M7418 | Tocrifluor T1117 | Others |
| Tocrifluor T1117 is a fluorescent cannabinoid ligand; fluorescent form of AM 251. | ||
| M8919 | BAY 59-3074 | Cannabinoid |
| BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively. | ||
| M7613 | 2-Arachidonyl glycerol | Cannabinoid |
| 2-AG | ||
| 2-Arachidonyl glycerol is an endogenous cannabinoid and also an agonist at cannabinoid receptors. | ||
| M7821 | GW833972A | Others |
| GW833972A is a CB2 cannabinoid receptor agonist with 1000-fold selectivity relative to CB1. | ||
| M7970 | NIDA-41020 | Others |
| NIDA-41020 is a CB1 cannabinoid receptor antagonist. | ||
| M7997 | Palmitoylethanolamide | Anti-infection |
| Palmitoylethanolamide (Palmidrol) is an active endogenous CB2 cannabinoid receptor agonist. | ||
| M8377 | UCM710 | Others |
| UCM710 is a dual inhibitor of fatty acid amide hydrolase (FAAH) and α/β hydrolase domain 6 (ABHD6) the enzymes that hydrolyze endocannabinoids. | ||
| M8596 | WWL70 | Others |
| WWL70 is a selective inhibitor of α/β-hydrolase domain-containing 6 (ABHD6), a serine hydrolase that acts as an alternative hydrolase of the endocannabinoid 2-arachidonoylglycerol (2-AG). | ||
| M8674 | AM4113 | Cannabinoid |
| AM4113 is a Cannabinoid CB-1 neutral antagonist. | ||
| M8689 | JJKK-048 | MAGL |
| JJKK-048 is a cell penetrant ultrapotent and highly selective inhibitor of monoacylglycerol lipase (MAGL) that exhibits a low cross-reactivity with other endocannabinoid targets. | ||
| M8725 | SR144528 | Others |
| SR144528 is a potent and highly selective cannabinoid CB2 receptor inverse agonist. | ||
| M8735 | GAT211 | Others |
| GAT211 is a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling. | ||
| M8749 | GAT228 | Others |
| GAT228 is the R-(+)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of psychoactivity or tolerance. | ||
| M8985 | LY2828360 | Cannabinoid |
| LY2828360 is a novel potent, selective, and efficacious CB2 cannabinoid agonist. | ||
| M9691 | JD-5037 | Cannabinoid |
| JD5037; CRB-4001 | ||
| JD-5037 is a cannabinoid-1 receptor blocker (CB1R antagonist) with IC50 of 1.5 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
